B-Lymphocyte Signalling Abnormalities and Lupus Immunopathology

REFERENCES

• Ehrenstein M, Isenberg DA. Systemic lupus erythematosus in adults –clinical features and aetiopathogenesis. In: Isenberg DA, Maddison P, Woo P, Glass D, Breedveld F, editors. Oxford textbook of rheumatology. 3rd ed. New York: Oxford University Press Inc.; 2004. pp. 819–841.
   Google Scholar
• Sestak AL, Fürnrohr BG, Harley JB, The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis 2011 Mar;70(Suppl 1):i37–i43.
   Google Scholar
• Rhodes B, Vyse TJ. The genetics of SLE: an update in the light of genome-wide association studies. Rheumatol 2008;47:1603–1611.
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D, Alarcon-Requelme ME, Cardiel MH, Grupo Latinoamericano de Estudio del lupus Eritematoso (GLADEL). Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005;52:1138–1147.
   PubMed Web of Science ®Google Scholar
• Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004;22:431–456.
   PubMed Web of Science ®Google Scholar
• Li X, Ptacek TS, Brown EE, Edberg JC. Fcgamma receptors: structure, function and role as genetic risk factors in SLE. Genes Immun 2009;10:380–389.
   PubMed Web of Science ®Google Scholar
• Lee-Kirsch MA, Gong M, Chowdhury D, Mutations in the gene encoding the 30–50 DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007;39:1065–1067.
   PubMed Web of Science ®Google Scholar
• Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006;6:728–740.
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res 2002;4(Suppl 3):S279–S293.
   Google Scholar
• Harley JB, Alarcón-Riquelme ME, Criswell LA, Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008;40:204–210.
   PubMed Web of Science ®Google Scholar
• Kaliyaperumal A, Mohan C, Wu W, Datta SK. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med 1996;183:2459–2469.
   PubMed Web of Science ®Google Scholar
• Zeng D, Dick M, Cheng L, Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J Exp Med 1998;187:525–536.
   PubMedGoogle Scholar
• Takahashi T, Strober S. Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur J Immunol 2008;38:156–165.
   PubMed Web of Science ®Google Scholar
• Bonelli M, Smolen JS, Scheinecker C. Treg and lupus. Ann Rheum Dis 2010;69(Suppl 1):i65–66.
   Google Scholar
• Vassilopoulos D, Kovacs B, Tsokos GC. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 1995;155:2269–2281.
   PubMed Web of Science ®Google Scholar
• Tsokos GC, Liossis SN. Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 1999;20:119–124.
   PubMedGoogle Scholar
• Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063–2073.
   PubMed Web of Science ®Google Scholar
• Blair PA, Noreña LY, Flores-Borja F, CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010;32:129–140.
   PubMed Web of Science ®Google Scholar
• Herndon TM, Juang YT, Solomou EE, Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol 2002;103:145–153.
   PubMedGoogle Scholar
• Reininger L, Winkler T, Kalberer CP, Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice. J Exp Med 1996;184:853–861.
   PubMed Web of Science ®Google Scholar
• Mageed RA, Prud'homme GJ. Immunopathology and the gene therapy of lupus. Gene Ther 2003;10:861–874.
   PubMed Web of Science ®Google Scholar
• Yurasov S, Wardemann H, Hammersen J, Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005;201:703–711.
   PubMed Web of Science ®Google Scholar
• Rönnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006;54:408–420.
   PubMed Web of Science ®Google Scholar
• Braun D, Caramalho I, Demengeot J. IFN-alpha/beta enhances BCR-dependent B cell responses. Int Immunol 2002;14:411–419.
   PubMed Web of Science ®Google Scholar
• Graham RR, Kozyrev SV, Baechler EC, A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006;38:550–555.
   PubMed Web of Science ®Google Scholar
• Nguyen KB, Watford WT, Salomon R, Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 2002;297:2063–2066.
   PubMed Web of Science ®Google Scholar
• Graninger WB, Hassfeld W, Pesau BB, Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Rheumatol 1991;18:1621–1622.
   PubMed Web of Science ®Google Scholar
• Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 2006;8(Suppl 2): S2.
   Google Scholar
• Gilbert MR, Wagner NJ, Jones SZ, Autoreactive pre plasma cells break tolerance in the absence of regulation by dendritic cells and macrophages. J Immunol 2012;189:711–720.
   Google Scholar
• Mitsdoerffer M, Lee Y, Jäger A, Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA 2010;107:14292–14297.
   PubMed Web of Science ®Google Scholar
• Zouali M, Sarmay G. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment. Arthritis Rheum 2004;50:2730–2741.
   PubMed Web of Science ®Google Scholar
• Tolar P, Sohn HW, Pierce SK. The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer. Nat Immunol 2005;6: 1168–1176.
   PubMed Web of Science ®Google Scholar
• Dal Porto JM, Gauld SB, Merrell KT, B cell antigen receptor signaling 101. Mol Immunol 2004;41:599–613.
   Google Scholar
• Kurosaki T, Shinohara H, Baba Y. B cell signaling and fate decision. Annu Rev Immunol 2010;28:21–55.
   PubMed Web of Science ®Google Scholar
• Liossis SNC, Solomou EE, Dimopoulos MA, B-cell kinase Lyn deficiency in patients with systemic lupus erythematosus. J Investig Med 2001;49:157–165.
   PubMed Web of Science ®Google Scholar
• Flores-Borja F, Kabouridis PS, Jury EC, Decreased Lyn expression and translocation to lipid raft signalling domains in B-lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:3955–3965.
   PubMed Web of Science ®Google Scholar
• Cornall R, Cyster J, Hibbs M, Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 1998;8:497–508.
   PubMed Web of Science ®Google Scholar
• Mary C, Laporte C, Parzy D, Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J Immunol 2000;165:2987–2996.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Hirose S, Sanokawa-Akakura R, Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int Immunol 1999;11:1685–1691.
   PubMed Web of Science ®Google Scholar
• Hom G, Graham RR, Modrek B, Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008;358:900–909.
   PubMed Web of Science ®Google Scholar
• Gross AJ, Lyandres JR, Panigrahi AK, Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J Immunol 2009;182:5382–5392.
   Google Scholar
• Flores-Borja F, Kabouridis PS, Jury EC, Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 2007;56:291–302.
   PubMed Web of Science ®Google Scholar
• Hermiston ML, Tan AL, Gupta VA, The juxtamembrane wedge negatively regulates CD45 function in B cells. Immunity 2005;23:635–647.
   Google Scholar
• Irie-Sasaki J, Sasaki T, Matsumoto W, Penninger JM. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signaling. Nature 2001;409:349–354.
   PubMed Web of Science ®Google Scholar
• Roach T, Slater S, Koval M, CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol 1997;7:408–417.
   PubMedGoogle Scholar
• Piercy J, Petrova S, Tchilian EZ, Beverley PC. CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells. Immunol 2006;118:250–256.
   Google Scholar
• Gregori S, Mangia P, Bacchetta R, An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells. J Exp Med 2005;201:1293–1305.
   PubMedGoogle Scholar
• Brooks WP, Lynes MA. Effects of hemizygous CD45 expression in the autoimmune Fasl(gld/gld) syndrome. Cell Immunol 2001;212:24–34.
   Google Scholar
• Greer SF, Justement LB. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1. J Immunol 1999;162:5278–5286.
   Google Scholar
• Benatar T, Carsetti R, Furlonger C, Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J Exp Med 1996;183:329–334.
   PubMed Web of Science ®Google Scholar
• Cyster JG, Healy JI, Kishihara K, Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 1996;381:325–328.
   PubMedGoogle Scholar
• Taher TE, Parikh K, Flores-Borja F, Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 2010;62:2412–2423.
   PubMed Web of Science ®Google Scholar
• Dhand R, Hara K, Hiles I, PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J 1994;13:511–521.
   PubMedGoogle Scholar
• Lehmann K, Müller JP, Schlott B, PI3Kgamma controls oxidative bursts in neutrophils via interactions with PKCalpha and p47phox. Biochem J 2009;419:603–610.
   Google Scholar
• Geering B, Cutillas PR, Nock G, Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci USA 2007;104:7809–7814.
   PubMed Web of Science ®Google Scholar
• Pirola L, Zvelebil MJ, Bulgarelli-Leva G, Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase alpha (PI3Kalpha). Functions of lipid kinase-deficient PI3Kalpha in signaling. J Biol Chem 2001;276:21544–21554.
   PubMedGoogle Scholar
• Bi L, Okabe I, Bernard DJ, Nussbaum RL. Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase. Mamm Genome 2002;13:169–172.
   PubMed Web of Science ®Google Scholar
• Hirsch E, Katanaev VL, Garlanda C, Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000;287:1049–1053.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Irie-Sasaki J, Jones RG, Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000;287:1040–1046.
   PubMed Web of Science ®Google Scholar
• Clayton E, Bardi G, Bell SE, A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 2002;196:753–763.
   PubMed Web of Science ®Google Scholar
• Jou ST, Carpino N, Takahashi Y, Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 2002;22:8580–8591.
   PubMed Web of Science ®Google Scholar
• Barber DF, Bartolomé A, Hernandez C, PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 2005;11:933–935.
   PubMed Web of Science ®Google Scholar
• Bilancio A, Okkenhaug K, Camps M, Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood 2006;107:642–650.
   PubMed Web of Science ®Google Scholar
• Maxwell MJ, Tsantikos E, Kong AM, Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease. J Autoimmun 2012;38:381–391.
   PubMed Web of Science ®Google Scholar
• Suárez-Fueyo A, Barber DF, Martínez-Ara J, Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death. J Immunol 2011;187:2376–2385.
   PubMed Web of Science ®Google Scholar
• Omori SA, Cato MH, Anzelon-Mills A, Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signalling. Immunity 2006;25:545–557.
   PubMed Web of Science ®Google Scholar
• Omori SA, Rickert RC. Phosphatidylinositol 3-kinase (PI3K) signalling and regulation of the antibody response. Cell Cycle 2007;6:397–402.
   PubMed Web of Science ®Google Scholar
• Fruman DA, Mauvais-Jarvis F, Pollard DA, Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat Genet 2000;26: 379–382.
   PubMed Web of Science ®Google Scholar
• Okkenhaug K, Bilancio A, Farjot G, Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 2002;297:1031–1034.
   PubMed Web of Science ®Google Scholar
• Durand CA, Hartvigsen K, Fogelstrand L, Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol 2009;183:5673–5684.
   PubMed Web of Science ®Google Scholar
• Webb LM, Vigorito E, Wymann MP, Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase. J Immunol 2005;175:2783–2787.
   PubMed Web of Science ®Google Scholar
• Dil N, Marshall AJ. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation. Mol Immunol 2009;46:1970–1978.
   PubMed Web of Science ®Google Scholar
• Marone R, Cmiljanovic V, Giese B, Wymann MP. Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 2008;1784:159–185.
   PubMed Web of Science ®Google Scholar
• Rommel C, Camps M, Ji H. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 2007;7:191–201.
   PubMed Web of Science ®Google Scholar
• Camps M, Rückle T, Ji H, Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005;11:936–943.
   PubMed Web of Science ®Google Scholar
• Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006;6:823–835.
   PubMed Web of Science ®Google Scholar
• Verdolini R, Bugatti L, Giangiacomi M, Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br J Dermatol 2002;146:877–881.
   PubMedGoogle Scholar
• Tomita H, Yamada M, Sekigawa I, Systemic lupus erythematosus-like autoimmune abnormalities induced by bacterial infection. Clin Exp Rheumatol 2003;21:497–499.
   PubMedGoogle Scholar
• Werling D, Jungi TW. TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol 2003;91:1–12.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato S, Hemmi H, Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003;301:640–643.
   PubMed Web of Science ®Google Scholar
• Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann NY Acad Sci 2008;1143:21–34.
   PubMed Web of Science ®Google Scholar
• Sadanaga A, Nakashima H, Akahoshi M, Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum 2007;56:1618–1628.
   PubMedGoogle Scholar
• Pawar RD, Ramanjaneyulu A, Kulkarni OP, Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol 2007;18:1721–1731.
   PubMed Web of Science ®Google Scholar
• Christensen SR, Shupe J, Nickerson K, Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006;25:417–428.
   PubMed Web of Science ®Google Scholar
• Ehlers M, Fukuyama H, McGaha TL, TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 2006;203:553–561.
   PubMed Web of Science ®Google Scholar
• Papadimitraki ED, Choulaki C, Koutala E, Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 2006;54:3601–3611.
   PubMed Web of Science ®Google Scholar
• Eloranta ML, Lövgren T, Finke D, Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum 2009;60:2418–2427.
   PubMed Web of Science ®Google Scholar
• Chaturvedi A, Dorward D, Pierce SK. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 2008;28: 799–809.
   PubMed Web of Science ®Google Scholar
• Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000;1:11–21.
   PubMed Web of Science ®Google Scholar
• Dugas B, Calenda A, Delfraissy JF, The cytosolic free calcium in anti-mu-stimulated human B cells is derived partly from extracellular medium and partly from intracellular stores. Eur J Immunol 1987;17:1323–1328.
   PubMed Web of Science ®Google Scholar
• Peinelt C, Vig M, Koomoa DL, Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol 2006;8:771–773.
   PubMed Web of Science ®Google Scholar
• Wu MM, Buchanan J, Luik RM, Lewis RS. Ca2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. J Cell Biol 2006;174:803–813.
   PubMed Web of Science ®Google Scholar
• Putney JW Jr, Broad LM, Braun FJ, Mechanisms of capacitative calcium entry. J Cell Sci 2001;114:2223–2229.
   PubMed Web of Science ®Google Scholar
• Lyubchenko T, dal Porto J, Cambier JC, Holers VM. Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway. J Immunol 2005;174:3264–3272.
   Google Scholar
• Kulik L, Marchbank KJ, Lyubchenko T, Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development. Eur J Immunol 2007;37:623–633.
   Google Scholar
• Lyubchenko T, Dal Porto JM, Holers VM, Cambier JC. Cutting edge: Complement (C3d)-linked antigens break B cell anergy. J Immunol 2007;179:2695–2699.
   Google Scholar
• Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol 2007;7:633–643.
   PubMed Web of Science ®Google Scholar
• Yarkoni Y, Getahun A, Cambier JC. Molecular underpinning of B-cell anergy. Immunol Rev 2010;237:249–263.
   PubMedGoogle Scholar
• Gauld SB, Benschop RJ, Merrell KT, Cambier JC. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol 2005;6:1160–1167.
   PubMed Web of Science ®Google Scholar
• Bednarski JJ, Lyssiotis CA, Roush R, A novel benzodiazepine increases the sensitivity of B cells to receptor stimulation with synergistic effects on calcium signaling and apoptosis. J Biol Chem 2004;279:29615–29621.
   Google Scholar
• Cunninghame Graham DS, Graham RR, Manku H, Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 2008;40:83–89.
   PubMed Web of Science ®Google Scholar
• Garaud S, Le Dantec C, Jousse-Joulin S, IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 2009;182:5623–5632.
   PubMed Web of Science ®Google Scholar
• Remmers EF, Plenge RM, Lee AT, STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007;357:977–986.
   PubMed Web of Science ®Google Scholar
• Nishizumi H, Yamamoto T. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. J Immunol 1997;158:2350–2355.
   PubMedGoogle Scholar
• Kitaura Y, Jang IK, Wang Y, Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity 2007;26:567–578.
   PubMed Web of Science ®Google Scholar
• Kil LP, de Bruijn MJ, van Nimwegen M, Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood 2012;119:3744–3756.
   PubMed Web of Science ®Google Scholar
• Halcomb KE, Musuka S, Gutierrez T, Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells. Mol Immunol 2008;46:233–241.
   PubMed Web of Science ®Google Scholar
• O'Keefe TL, Williams GT, Davies SL, Neuberger MS. Hyperresponsive B cells in CD22-deficient mice. Science 1996;274:798–801.
   PubMed Web of Science ®Google Scholar
• O'Keefe TL, Williams GT, Batista FD, Neuberger MS. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 1999;189:1307–1313.
   PubMed Web of Science ®Google Scholar
• Huck S, Le Corre R, Youinou P, Zouali M. Expression of B cell receptor-associated signaling molecules in human lupus. Autoimmunity 2001;33(3):213–224.
   PubMed Web of Science ®Google Scholar
• Shultz LD, Schweitzer PA, Rajan TV, Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993;73:1445–1454.
   PubMed Web of Science ®Google Scholar
• Saito E, Fujimoto M, Hasegawa M, CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 2002;109:1453–1462.
   PubMed Web of Science ®Google Scholar
• Sato S, Hasegawa M, Fujimoto M, Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000;165:6635–6643.
   PubMed Web of Science ®Google Scholar
• Kuroki K, Tsuchiya N, Tsao BP, Polymorphisms of human CD19 gene: possible association with susceptibility to systemic lupus erythematosus in Japanese. Genes Immun 2002;3(Suppl 1): S21–S30.
   Google Scholar
• Zhang W, Shi Q, Xu X, Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes. PLoS One 2012;7:e41644.
   PubMed Web of Science ®Google Scholar
• Grammer AC, Slota R, Fischer R, Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J Clin Invest 2003;112: 1506–1520.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Aiba Y, Nomura T, Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 2002;168:9–12.
   PubMed Web of Science ®Google Scholar
• Li X, Wu J, Carter RH, A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 2003;48:3242–3252.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34–47.
   PubMed Web of Science ®Google Scholar
• Panchanathan R, Shen H, Duan X, Aim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility protein. J Immunol 2011;186:6762–6770.
   PubMed Web of Science ®Google Scholar
• Chu VT, Enghard P, Schürer S, Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus. Arthritis Rheum 2009;60:2083–2093.
   PubMed Web of Science ®Google Scholar
• Zhang J, Roschke V, Baker KP, Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 2001;166:6–10.
   PubMed Web of Science ®Google Scholar
• Mackay F, Woodcock SA, Lawton P, Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999;190:1697–1710.
   PubMed Web of Science ®Google Scholar
• Hwang SH, Lee H, Yamamoto M, B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J Immunol 2012;189:5786–5796.
   PubMed Web of Science ®Google Scholar
• Richez C, Blanco P, Rifkin I, Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine 2011;78:124–130.
   PubMed Web of Science ®Google Scholar
• Jacob N, Guo S, Mathian A, B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J Immunol 2011;186:4984–4993.
   PubMed Web of Science ®Google Scholar
• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929–939.
   PubMed Web of Science ®Google Scholar
• Koenig KF, Groeschl I, Pesickova SS, Serum cytokine profile in patients with active lupus nephritis. Cytokine 2012;60:410–416.
   PubMed Web of Science ®Google Scholar
• Wu T, Qin X, Kurepa Z, Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest 2007;117:2186–2196.
   PubMed Web of Science ®Google Scholar
• Grammer AC, Fischer R, Lee O, Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals. Arthritis Res Ther 2004;6:28–38.
   PubMed Web of Science ®Google Scholar
• Wong CK, Wong PT, Tam LS, Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus. J Clin Immunol 2009;29:738–746.
   PubMedGoogle Scholar
• Lee SR, Rutan JA, Monteith AJ, Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells. J Immunol 2012;189:3859–3868.
   Google Scholar
• Nicholas MW, Dooley MA, Hogan SL, A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol 2008;126:189–201.
   PubMed Web of Science ®Google Scholar
• Huang X, Guo Y, Bao C, Shen N. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One 2011;6:e21671.
   PubMed Web of Science ®Google Scholar